1,3-Dioxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindol-2(3H)-yl 4-nitrobenzyl carbonate, 95.0%, 250mg

2-Chloro-6-fluoro-3-formylphenylboronic acid, 98+%, 1g

2-METHYL-2H-INDAZOLE-4-CARBONITRILE, 95.0%, 1g

4-(2-CHLOROPHENOXY)BENZYLAMINE HCL, 95.0%, 1g

Salicylic acid, min. 99%, for biochemistry, 500 g, plastic packaging.

Abacavir, 95.0%, 250mg

7,8-Dihydro-2-methyl-1H-thiopyrano[4,3-d]pyrimidin-4(5H)-one, 95.0%, 100mg

(1R,3R,E)-5-(2-((1R,3aS,7aR,E)-7a-Methyl-1-((R)-6-methylheptan-2-yl)octahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol, 98%, 1mg

(R)-1-(tert-Butoxycarbonyl)-4-oxopyrrolidine-2-carboxylic acid, 95.0%, 5g

N,N-Dimethyl-2-(perfluorophenoxy)ethanamine, 97.0%, 10g

2-Chloro-4-(3-methoxyphenyl)pyrimidine, 95.0%, 1g

Adamantan-2-amine, 95.0%, 5g

Ethyl 4-aminobenzoate, 98.0%, 1kg